Board Member
Grace Therapeutics, Inc. (GRCE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Vimal Kavuru is recorded as Board Member at Grace Therapeutics, Inc. (GRCE). Grace Therapeutics, Inc. reported in an 8-K filed September 30, 2024 that Vimal Kavuru was appointed director, effective September 30, 2024. Grace Therapeutics, Inc. reported in an 8-K filed September 29, 2022 that Vimal Kavuru was appointed director, effective September 28, 2022. Vimal Kavuru has spoken on 1 investor event across 1 company, most recently for Grace Therapeutics, Inc. on September 17, 2026.
“The following nominees were elected as directors by the votes indicated to serve until the close of the Company’s next annual meeting of shareholders or until his successor is elected or appointed: | Nominee | Votes For | Withheld | Broker Non-Votes | | --- | --- | --- | --- | | Vimal Kavuru | 5,883,771 | 71,334 | 1,194,221 |”
“Jean Marie (John) Canan, Jan D’Alvise, Donald Olds, Vimal Kavuru and Michael L. Derby were elected as directors of Acasti at the Meeting to serve for a term that expires at the 2023 annual meeting of Acasti shareholders or until their successors are duly elected or appointed, unless such office is earlier vacated in accordance with Acasti’s by-laws.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-09-30–present
Recorded roles and call appearances connecting this person to public companies.
Board Member
2024-09-30–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
